Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus fermentum CECT5716

Safety profile

3 studies reporting safety data

Across 3 clinical studies, no specific adverse events were quantitatively reported for Lactobacillus fermentum CECT5716. The probiotic was described as well tolerated in all studies, with no significant differences in safety markers observed. One study reported similar rates of diarrhea between the supplement and control groups (7.84% vs 8.0%), but this was not flagged as a significant difference.

Caveats: Limited evidence base; absence of reports does not establish safety. Most studies were likely not designed to detect rare adverse events, and long-term safety data are lacking.

Most-studied combinations with Lactobacillus fermentum CECT5716

most supplement research is combination research
Also studied with:Lactobacillus reuteri NCIMB 30242 (2)
  • Mum

    By BioGaia

    Out of Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $28.99
    In
    Vitacost
    $-
    Out
    Vitamin Shoppe
    $-
    Out
Back to top